DCAT Value Chain Insights

The Marriage of Mylan and Pfizer's Upjohn

Earlier this month, Mylan and Pfizer agreed to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business. The deal is expected to close in mid-2020 and will...

Generic-Drug Approvals: FDA OK in First Review Hard to Get

A recent analysis by the US Government Accountability Office shows that only 12% of the 2,030 generic drug applications reviewed by the FDA from fiscal years 2015 through 2017 were approved in the...

A winning pediatric dosage formulation

Information
March 6, 2019
Sponsored by Cambrex

When a global pharmaceutical company’s pediatric formulation and dosage form(s) didn’t fit the plant equipment profile used to manufacture the adult dosage form at the customer’s facility, they...

Read More
Cambrex eBook - Small molecules 2.0: the bigger picture

Information
February 20, 2019
Sponsored by Cambrex

The Cambrex eBook contains 30 more thought leading articles from the world's fastest growing small molecule company. Discover the highest number of NCEs approved by the FDA.

Read More
Continuous Flow for APIs and Intermediates (Part 2)

Information
February 13, 2019
Sponsored by Cambrex

Cambrex’s Dr. Shawn Conway, Director of Engineering, R&D, outlines how continuous flow processes simplify and break through traditional method limitations to achieve efficiencies in cost, quality and...

Read More